至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen

Biotechnol Bioeng. 2021-06; 
Renata G F Alvim, Túlio M Lima, Jerson L Silva, Guilherme A P de Oliveira, Leda R Castilho
Products/Services Used Details Operation
Gene Synthesis … The gene construct was codon-optimized, synthetized, subcloned into pCIneo vector (Promega, USA) and supplied ready to transfect by Genscript (USA). Approximately 48h post-transfection (hpt), cells were transferred to a vented 125 mL … Get A Quote

摘要

Yellow fever (YF) is a life-threatening viral disease endemic in parts of Africa and Latin America. Although there is a very efficacious vaccine since the 1930s, YF still causes 29,000-60,000 annual deaths. During recent YF outbreaks there were issues of vaccine shortage of the current egg-derived vaccine; rare but fatal vaccine adverse effects occurred; and cases were imported to Asia, where the circulating mosquito vector could potentially start local transmission. Here we investigated the production of YF virus-like particles (VLPs) using stably transfected HEK293 cells. Process intensification was achieved by combining sequential FACS (fluorescence-activated cell sorting) rounds to enrich the stable cell po... More

关键词

FACS for high producers, HEK293 cells, perfusion cultivation, stable expression, virus-like particles (VLPs), yellow fever virus